Asep Inc. Obtains Exclusive Worldwide License from the University of British Columbia for Ground-breaking Medical Device Coating Technology by asepadmin | Aug 1, 2023 | Uncategorized
Another Breakthrough — Asep Inc.’s A.I.-Based Sepsis Technology Identifies COVID-19 Severity from a Blood Sample by asepadmin | Jul 18, 2023 | Uncategorized
Asep Inc. Completes Submission of Registration Statement for NASDAQ Listing by asepadmin | Jul 5, 2023 | Uncategorized
Asep Inc. Receives Grant from NanoMedicines Innovation Network (NMIN), Funded by the Government of Canada The New Grant Will Support Important Pre-clinical Studies by asepadmin | Jun 26, 2023 | Uncategorized
Asep Inc. Founder, Chair and CEO, Dr. Robert E. W. Hancock, Ranked 4th Best Microbiologist in the World by asepadmin | Jun 20, 2023 | Uncategorized